English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Information on the pharmacokinetic interactions of 8 statins (atorvastatin, simvastatin, lovastatin, fluvastatin, pravastatin, rosuvastatin, pitavastatin and cerivastatin (already withdrawn from the market)) with other drugs such as itraconazole, erythromycin, HIV protease inhibitors, digoxin and cyclosporine, and food products such as grapefruit juice was collected from the literature, summarized and analyzed. The results of clinical drug interaction(s) were then discussed on the basis of nonclinical interaction information regarding hepatic or intestinal metabolism by cytochrome P 450 and drug transporters such as MDR 1 and OATP 2.In conclusion, due to several complicating factors such as plasma protein binding, first pass effect, lipophilicity/hydrophilicity, and inter-conversion between acid and lactone forms, further clinical pharmacokinetic interaction studies will be needed to predict the likelihood of drug interactions.

Comparative Analysis of Clinical and Non-Clinical Pharmacokinetic Interactions of Statins with Other Drugs